Axos Invest Inaugurates Self-Directed Trading With $100 Account-Opening Bonus

SAN DIEGO--(BUSINESS WIRE)-- Axos Invest, the retail investing arm of digital financial services leader Axos Financial, Inc., announced today that it is offering a $100 cash bonus to eligible customers who open an account on its new Self-Directed Trading platform.

Launched earlier this year, Axos Invest Self-Directed Trading offers commission-free trades on eligible stocks, Exchange-Traded Funds (ETFs) and no-load mutual funds ($0 per trade on eligible stocks and ETFs; other fees may apply). Self-Directed Trading carries no annual fees or inactivity charges.

The bonus offer applies to customers who open their first Self-Directed Trading account with a minimum funding level of $2,500 by Dec. 31, 2021.

“We had one simple goal in creating Axos Invest: to ensure that every client has access to the investment services they need to accomplish their wealth goals,” said Tracy Gallman, SVP Axos Invest.

For more information about the bonus for opening an Axos Invest Self-Directed Trading account, and to review all terms and disclosures, please visit https://www.axos.com/AxosInvest100.

About Axos Invest

As the retail investing arm of digital financial services provider Axos Financial (NYSE: AX), Axos Invest empowers Americans to meet their wealth goals with low- to no-fee investing. In 2013, Axos Invest launched the world’s first no-fee financial advisor, helping clients achieve their goals by automating the financial planning process. Building on its Managed Portfolios platform, Axos Invest launched Self-Directed Trading in 2021, offering investors commission-free trades on eligible stocks, ETFs and no-load mutual funds, plus options and margin trading for approved customers.

Securities and other non-deposit investment products and services are not deposits, obligations of or guaranteed by Axos Bank, are not insured by the FDIC or any governmental agency, and are subject to investment risk including possible loss of the principal invested. Past performance of a security does not guarantee future results or success.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211108005067/en/

Greg Frost
SVP, Corporate Communications
Axos Bank
Phone: 1-858-376-6370
Email: [email protected]

Source: Axos Invest

You May Also Be Interested In

• TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
• Charlotte Tilbury awarded CBE in the King’s Birthday Honours 2026
• Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes